Medication for opioid use disorder (MOUD) involves a combination of a medications that targets the brain and psychosocial interventions (e.g., counseling, skills development) aimed at improving treatment outcomes. SAMHSA and the ACOG recommend treatment with methadone or buprenorphine for pregnant women with opioid use disorder, in conjunction with behavioral therapy and medical services. More from ACOG.
MACS provides trainings for Maryland maternal health providers to provide MOUD. Buprenorphine is one of three medications approved by the FDA for the treatment of opioid use disorder in pregnant people.
Visit the MACS website for more information on prescribing buprenorphine for OUD.
Additional Training Resources: